Full Professor(heuristic)

Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine

Compare more Pulmonary and Respiratory Medicine professors.

h-index107
i10-index531
Publications1,978
Citations47,684

Grants

4 total · 1 active

NIH #K12CA088084

Paul Calabresi Clinical Oncology Award

Active
Amount
$800K–$900K
Period
2000-09-132027-06-30
PIs
3

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #P30CA016672

12 Clinical and Translational Research Center

Amount
$300K–$400K
Period
1996-08-282026-06-30
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA242565

Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy

Amount
$300K–$400K
Period
2019-06-052024-11-30
PIs
3

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

4 total · 1 active

NIH #K12CA088084

Paul Calabresi Clinical Oncology Award

Active
Amount
$800K–$900K
Period
2000-09-132027-06-30
PIs
3

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #P30CA016672

12 Clinical and Translational Research Center

Amount
$300K–$400K
Period
1996-08-282026-06-30
PIs
1

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA242565

Use of Patient-Reported Outcomes in Understanding Symptomatic Adverse Events in Early-Phase Trials of Combination Treatments that Include Immune Checkpoint Inhibitors and Targeted Therapy

Amount
$300K–$400K
Period
2019-06-052024-11-30
PIs
3

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #R01CA187238

Therapeutic Strategies for Patients With BRAF Mutant Colorectal Cancer

Amount
$300K–$400K
Period
2014-08-042020-07-31
PIs
2

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Recent Public Signals

  1. New paper: Supplemental Table 6 from Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer2026-06-17
  2. New NIH award: Paul Calabresi Clinical Oncology Award2000-09-13

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-01

Data may not be current

Find elsewhere

ORCID: 0000-0001-8721-1609

Professor Insights

Career Trajectory